Imperial Chemical Industries (ICI) was a British chemical company and was, for much of its history, the largest manufacturer in Britain. It was formed by the merger of leading British chemical companies in 1926. Its headquarters were at Millbank in London, and it was a constituent of the FT 30 and later the FTSE 100 indices.

Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Pharmaceuticals, Information Service, and Others. The Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism. The Information Service segment offers information services to use in IT and capital investment. The Others segment includes merchandise sales and construction contractors. The company was founded on August 9, 1946 and is headquartered in Matsumoto, Japan.

Zeneca is a British multinational pharmaceutical company focused on therapeutic oncology and cardiovascular products. Zeneca was established in June 1993 through a demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries. In 1999 Zeneca and Astra AB, a Sweden-based pharmaceutical company, merged to form AstraZeneca plc.

Applied Therapeutics operates as a biotechnology company. The company focuses on developing transformative drugs in areas of high unmet medical need -fatal and debilitating diseases for which no therapies are approved. The company is developing a pipeline of novel product candidates against previously validated and well-known molecular targets. It uses technological advances and abbreviated regulatory pathways, wherever possible, to design drugs for indications of significant unmet medical needs.

MipSalus ApS is a Danish private company located in Hørsholm. The firm engages in research and experimental development on natural sciences and engineering.

The Research Institute at Nationwide Children's Hospital is one of America's ten largest free-standing pediatric research centers and works to enhance the health of children by engaging in research.

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA.

Syngenta AG is a global company that produces agrochemicals and seeds and is based in Basel, Switzerland. As a biotechnology company, it conducts genomic research. It was formed in 2000 by the merger of Novartis Agribusiness and Zeneca Agrochemicals. As of 2014 Syngenta is the world’s largest crop chemical producer As of 2009 it ranked third in seeds and biotechnology sales. Sales in 2015 were approximately US$13.4 billion, over half of which were in emerging markets. It is owned by ChemChina, a Chinese state-owned enterprise.

Humedix Co., Ltd. engages in the manufacture and sale of hyaluronic acid based medical devices and arthritis treatment products. It offers dermal filler, specialty medicines, ophthalmic solvent, medicine raw materials, and cosmetics. The company was founded on February 27, 2003 and is headquartered in Anyang-si, South Korea.

Suntory Holdings Ltd. operates as a holding company with interests in the production and distribution of alcoholic and non-alcoholic beverages, health, beauty, and processed food products. Its services include formulation and promotion of group wide management strategies and corporate functions; sale of alcoholic beverages such as whiskey, beer, and wine; soft drinks; and other beverages such as tea and canned coffee. The company was founded by Shinjiro Torii in 1899 and is headquartered in Osaka, Japan.

Tianjin Hubin Pangu Gene Science Development Co., Ltd., established on 2014-05-07, Business scope includes gene technology and biological product research and development,technology transfer,technical consulting,Technical Services;medical instruments,drug development,Technology Consulting and Transfer;Biological product(food,except medicines)Wholesale and retail;Engage in import and export business permitted by national laws and regulations;account Serive.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jaguar Gene Therapy LLC is a company headquartered in Lake Forest, IL. The firm provides gene therapy for patients. Joe Nolan is the current CEO, occupying that position since 2020.\nThe company says this about itself: Jaguar Gene Therapy, LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases including those that impact sizeable patient populations. The company is made up of a proven team of experts with unparalleled CMC (Chemistry, Manufacturing and Controls), regulatory, clinical and commercial acumen who have first-hand experience in bringing novel gene therapy treatments to patients and their families. Committed to patient safety and product purity, Jaguar is rapidly advancing an initial pipeline of three programs targeting: 1) Type 1 galactosemia; 2) a genetic cause of autism spectrum disorder and Phelan-McDermid syndrome and other severe neurodevelopmental disorders with a SHANK3 mutation or deletion; and 3) Type 1 diabetes. The company continues to evaluate opportunities to expand its pipeline of investigational gene therapies.

Shanghai Jiehong New Material Technology Co., Ltd., established on 2011-03-01, The scope of business includes engaging in technology development in the field of new material science and technology,technical consulting,technology transfer,Technical Services,Business Management Consulting,business inquiries,Financial Advisory,account Serive,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)promotion of,Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Bionos Biotech specializes in efficacy testing for cosmetic and food-nutraceutical industries.

G.D. Searle, LLC is a wholly owned trademark of Pfizer. It is currently used mainly as a distribution trademark for various pharmaceuticals that were developed by G. D. Searle & Company (often referred to as Searle). Prior to its 1985 merger with Monsanto, Searle was a company focusing on life sciences, specifically pharmaceuticals, agriculture, and animal health.

Fenghua Biological specializes in the development and production of clinical testing instruments and supporting reagents.

Guangzhou Darui Biotechnology Co., Ltd. engages in the research and development, and application of prenatal and postnatal care, and precision medical products. Its products and instruments are used in prenatal screening, screening of newborns, cancer screening and individualized drug guide, detection of infectious diseases, and sex hormone test. Its technology platform includes high-throughput sequencing, gene chip, flight mass spectrometry, chemiluminescent, time-resolved, and tandem mass spectrometry platform. The company was founded on August 11, 2003 and is headquartered in Guangzhou, China.